Case Study – Odor Mitigation by The Platform
The Platform is a business development opportunity enabled by a technology platform based on a trade secret formulation of enzymes, penetrants and surfactants capable of activating natural agents in a system to do work. Specifically The Platform acts as a catalyst to help natural materials, such as bacteria, destroy pollutants. This work can be digesting waste, cleaning surfaces, managing biofilms etc.
It’s well recognized that natural systems are often the most cost effective in creating outcomes and often mimicked by human activities. Perhaps the most obvious example is treating human illnesses with antibiotics by copying natural processes and materials in the laboratory. The simple conclusion is that finding ways to help nature do what it does best can be very commercially attractive.
The Platform appears from field observations and published reports, to be able to facilitate natural processes to function more effectively. In essence, The Platform is behaving like a catalyst, meaning it can be employed at very low treatment levels, suggesting attractive economics.
A critical observation is that The Platform activity has been reported from fermented products indicating our observations are substantiated. However, fermented products are very limited in their applications since they must be prepared by biological processes. The Platform is a formulated product from readily available, low-risk materials, making it potentially very board in its applicability and not limited as other competitive naturally derived offerings.
The Platform has proven to be commercial effective of in 5 unique applications suggesting the basic mechanism of “catalytic system activation” is occurring. Successful commercialization has occurred in Municipal Waste Water Treatment (MWWT), lagoon treatment, cooling tower management, deodorization of air scrubber systems, and waste control of Concentrated Animal Farm Operations (CAFOs). These field observations are supported indirectly by laboratory results involving synergistic effects with known biocide compounds and microbial metabolism studies.
In every application, the value proposition has been compelling resulting in nearly universal acceptance of The Platform program at EBITDA returns in excess of 20%. Further, there have been no customer losses once The Platform program has been adopted.
The U. S. market potential of the aforementioned applications is $3-5 billion USD of which we believe ~$100 MM is accessible within a 3-5 year timeframe. In addition, geographic expansion and yet to be studied applications, such as biocide additives, CAFOs and aquaculture offer significant upside growth opportunity.